The Novel COVID-19 Infections in Iran: Management and Challenges
The novel coronavirus (COVID-19) was first identified in Wuhan, China, in December 2019 among a cluster of patients that presented with an unidentified form of viral pneumonia with a shared history of visiting the Huanan seafood market. The pathogen has been identified as a novel enveloped RNA Betac...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Shahid Sadoughi University of Medical Sciences
2020-12-01
|
| Series: | Journal of Evidence Based Health Policy, Management & Economics |
| Subjects: | |
| Online Access: | http://jebhpme.ssu.ac.ir/article-1-278-en.html |
| Summary: | The novel coronavirus (COVID-19) was first identified in Wuhan, China, in December 2019 among a cluster of patients that presented with an unidentified form of viral pneumonia with a shared history of visiting the Huanan seafood market. The pathogen has been identified as a novel enveloped RNA Betacoronavirus that has currently been named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and has a phylogenetic similarity to SARS-CoV. The World Health Organization (WHO) declared coronavirus disease 2019 (Covid-19), caused by SARS-COV2, is a public health emergency of international concern which is a threat to all countries including Iran. |
|---|---|
| ISSN: | 2538-5070 2538-4716 |